# Luminetx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/luminetx

- Industry: Biotechnology
- Headquarters: Memphis, US
- Website: www.luminetx.com
- Total disclosed funding: $15M
- Latest round: Series A (Oct 11, 2005)
- Investors on record: 6

## About

Luminetx specializes in innovative medical imaging solutions, notably the VeinViewer, which enhances vein visualization for healthcare professionals, improving patient outcomes in procedures like venipuncture.Founded in 2001 and headquartered in Memphis, US, Luminetx is dedicated to developing advanced medical imaging technologies. The company was acquired by Christie Digital Systems, Inc. in December 2009 for USD 15 mn. It has completed four deals to date, focusing on enhancing healthcare operations.Luminetx primarily focuses on its flagship product, the VeinViewer, an advanced imaging device designed for the medical sector. This device utilizes near-infrared light to visualize veins beneath the skin's surface, aiding healthcare professionals in procedures such as venipuncture and catheter insertions. The end-user demographic includes healthcare providers, including nurses and phlebotomists, as well as patients requiring venous access. Luminetx distributes its products across various geographical markets, particularly in North America, Europe, and select regions in Asia, ensuring a global footprint in the healthcare technology sector.Luminetx generates revenue primarily through direct sales of the VeinViewer to healthcare facilities such as hospitals and outpatient clinics, alongside partnerships with medical device distributors. The business model revolves around B2B transactions where healthcare providers purchase the devices outright or through leasing agreements. The company may also offer maintenance and support services, creating additional revenue streams tailored to client needs.Luminetx aims to leverage its recent acquisition by Christie Digital Systems, Inc. to further enhance its product offerings. The company is currently focused on developing new iterations of the VeinViewer with advanced imaging capabilities. Additionally, Luminetx plans to expand its market presence into new regions, particularly in Asia and Europe, to capture a larger share of the healthcare technology market. The funding from the acquisition will support these initiatives, aiding in research and development, as well as marketing efforts to establish a stronger foothold in emerging markets.

## Funding rounds

- Series A, Oct 11, 2005, $11M — Capvest Venture, Stanford Financial Group, Custer Capital, Diomed Holdings, Inc., Elm Ridge Capital Management – I
- Angel, May 2, 2005, $4M — Morgan Keegan & Co. - Private Funds Group

## Investors

- Morgan Keegan & Co. - Private Funds Group (https://capitalatlas.ai/funds/morgan-keegan-co-private-funds-group) — Angel
- Capvest Venture (https://capitalatlas.ai/funds/capvest-venture) — Series A
- Stanford Financial Group — Series A
- Custer Capital — Series A
- Diomed Holdings, Inc. — Series A
- Elm Ridge Capital Management – I — Series A